Buprenorphine is now recognized
The chief problem with painkillers like morphine, prescription painkillers like OxyContin and Vicodin is their abuse by a number of patients. These opiate drugs are powerful and abused, acting as they do on certain opiate receptors in the brain, which also regulate pain and emotions in the human body and mind. The “high” or effect of taking these prescription medicines has resulted in startling statistics, which demonstrate that over a million people in the United States alone are currently medical substance abusers.
A number of substances like Naltrexone and Methadone have previously been used in relieving patients from the harms of medical substance abuse or abuse of prescription drugs. Buprenorphine is the latest addition to this list of counter-addiction substances, as it is an agonist or antagonist, which targets the same opiate receptors in the brain that prescription drugs like morphine do, without producing the dangerous “high” that is a result or a side effect of the commonly used prescription drugs. And with the help of the buprenorphine treatment locator, it has become extremely easy for potential patients, their family members, doctors and counselors to locate physicians who are qualified to assist patients with opioid or opiate addictions using buprenorphine.
The buprenorphine treatment locator helps you search physicians who are qualified to suggest opiate de-addiction treatment like Suboxone and Subutex, or treatment programs that can help one get rid of the chain of addiction.
Statistics have shown that buprenorphine can be used alone or in combination with naloxone to assist opioid de-addiction. It is safe to use and has no addictive properties, nor does it have any side effects. It reduced addiction of prescription or opiate drugs significantly. However, it can create extreme “highs” while injected, though it does not show any adverse effects if taken orally.
Its novelty lies in its unique combination with naloxone, which is an opioid antagonist, ensuring that addiction tendencies are severely limited. The success story of buprenorphine, which is attested by the number of people using the buprenorphine treatment locator to seek help in de-addicting themselves or their loved ones, has also made such alternative options available to people that were earlier only part of federally approved treatment programs. The use of buprenorphine by physicians has widened the scope of de-addiction programs. More efforts are under way to test the efficacy of buprenorphine in helping adolescents, pregnant women, and aged patients to cope with the trauma of opioid addiction.